Results of a large meta-analysis involving 64,196 patients concluded that; when using > 25% ki67 (as high ki67 index) cutoff, ki67 index is an independent prognostic factor in terms of overall survival in breast cancer patients [18]. This evidence concerns the gene MKI67 and breast carcinoma.